A case of psoriasis vulgaris with peripheral blood eosinophilia, parallelling the psoriasis area and severity index (PASI) score [5]

Clinical and Experimental Dermatology

Volumn 29, Issue 5, 2004, Pages 549-550

  Sueki, H ^a   Nakada, T ^a   Iijima, M ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TACALCITOL;

ADULT; CASE REPORT; EOSINOPHILIA; FEMALE; HUMAN; JAPAN; LETTER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; PSORIASIS AREA AND SEVERITY INDEX SCORE; PSORIASIS VULGARIS; RATING SCALE;

ADMINISTRATION, TOPICAL; DERMATOLOGIC AGENTS; DIHYDROXYCHOLECALCIFEROLS; EOSINOPHILIA; FEMALE; HUMANS; MIDDLE AGED; OINTMENTS; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 4644310829     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01566.x     Document Type: Letter

References (5)

1. Lundin Å, Fredens K, Michaëlsson G et al. The granulocyte in psoriasis. Br J Dermatol 1990; 122: 181-93.
2. Kim T-Y, Park H-J, Kim C-W. Eosinophilic cationic protein (ECP) level in patients with various skin diseases. J Dermatol Sci 1997; 15: 89-94.
3. Barna M, Bos JD, Kapsenberg ML et al. Effect of calcitriol on the production of T-cell-derived cytokines in psoriasis. Br J Dermatol 1997; 136: 536-41.
4. Ockenfels HM, Schultewolter T, Ockenfels G et al. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol 1998; 139: 390-5.
5. Yawalkar N, Shrikhande M, Hari Y et al. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol 2000; 106: 1171-6.